Home   >  
Protease/Metabolic Enzyme
  • Protease/Metabolic Enzyme

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Aacocf3 Chemical Structure
BCP33391 Aacocf3 149301-79-1
AACOCF3 is a fatty acid derivative that is arachidonic acid in which the OH part of the carboxy group has been replaced by a trifluoromethyl group
CAY10650 Chemical Structure
BCP32595 CAY10650 1233706-88-1
CAY10650 is a potent cPLA2a inhibitor, demonstrating strong anti-inflammatory effects.
N-(p-amylcinnamoyl) Anthranilic Acid Chemical Structure
BCP30845 N-(p-amylcinnamoyl) Anthranilic Acid 110683-10-8
N-(p-amylcinnamoyl) Anthranilic Acid (ACA) is a broad spectrum Phospholipase A2 (PLA2) inhibitor and TRP channel blocker. N-(p-amylcinnamoyl) Anthranilic Acid (ACA) is also an effective reversible inhibitor of calcium-activated chloride channels, has potential to treat arrhythmia.
CAY10594 Chemical Structure
BCP30751 CAY10594 1130067-34-3
CAY10594 is a potent PLD2 inhibitor, both in vitro (IC50 = 140 nM) and in cells (IC50 = 110 nM). It is also effective as a PLD1 inhibitor at higher concentrations (IC50 = 5.1 μM in vitro, 1.0 μM in cells). CAY10594 strongly inhibits the invasive migration of breast cancer cells in transwell assays, suggesting that PLD might be a useful target in blocking tumor cell invasion.
Phospholipase A2 Chemical Structure
BCP29853 Phospholipase A2 9001-84-7
Phospholipases A2 (PLA2s) EC are enzymes that cleaves fatty acid in position two of phospholipids, hydrolyzing the bond between the second fatty acid “tail” and the glycerol molecule.
Varespladib sodium Chemical Structure
BCP20960 Varespladib sodium 172733-42-5
Varespladib Sodium is an intravenously administered inhibitor of secretory phospholipase A2 (sPLA2) with orphan drug designation.
GSK2814338 Chemical Structure
BCP23640 GSK2814338 1420367-28-7
GSK2814338 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.
Dodecyl Phosphocholine Chemical Structure
BCP17437 Dodecyl Phosphocholine 29557-51-5
Dodecylphosphocholine is a detergent. Dodecylphosphocholine is also a substrate-type inhibitor of pancreas phospholipase A2 (PLA2).
U73343 Chemical Structure
BCP12871 U73343 142878-12-4
U-73343 is a negative control (or inactive analogue) of U73122, which is a putative phospholipase C inhibitor.
VU-0155069 Chemical Structure
BCP29256 VU-0155069 1130067-06-9
VU-0155069 is a potent and selective phospholipase D1 (PLD1) inhibitor.
12下一页共 20 条记录 1 / 2 页